
About company
BioPlx is an advanced microbiome company that prevents infectious disease through the management of the microbiome. It employs targeted microbiological agents to create unique interventional formulations. The company developing non-antibiotic methods for the control of infectious disease, including multiple-drug resistance “super-bugs". BioPlx creates live bio-therapeutic products that are backed by clinical data showing exceptional magnitude and significance in both safety and efficacy based on solid science, a strong management team and a broad pool of the intellectual property. It is designed to use both in-house and proprietary contract development and consulting strategies across the wide range of components and methods incorporated within this product line.